Airbnb (ABNB), Lucid (LCID), Four Others to be Added to Nasdaq-100 Index (FTNT) (PANW) (ZS) (DDOG)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Trip.com Group (TCOM) Reports Q3 EPS of $0.13
December 15, 2021 5:03 PM ESTTrip.com Group (NASDAQ: TCOM) reported Q3 EPS of $0.13. Revenue for the quarter came in at $831 million.
For earnings history and earnings-related data on Trip.com Group (TCOM) click here.
... MoreIncyte (INCY) Announces Acceptance and Priority Review of sNDA for Ruxolitinib Cream as a Treatment for Patients with Vitiligo
December 14, 2021 4:31 PM ESTIncyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for ruxolitinib cream 1.5% (Opzelura) a topical JAK inhibitor, as a potential treatment for adolescents and adults (age 12 years) with vitiligo. The FDA grants Priority Review to medicines that may offer a major advance in treatment where none currently exists. The Prescription Drug User... More
Fortinet (FTNT) to be Added to Nasdaq-100 Index
December 13, 2021 4:40 PM ESTFortinet® (NASDAQ: FTNT), a global leader in broad, integrated and... More
